Previous 10 | Next 10 |
home / stock / bioyf / bioyf news
MISSISSAUGA, Ontario, March 09, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2022 on Tuesday, March 21, 2023 after market close. A prese...
MISSISSAUGA, Ontario, March 07, 2023 (GLOBE NEWSWIRE) -- On the eve of International Women’s Day , BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) celebrates the Canadian launch of Fera MAX ® Pd Maintenance 45 by its subsi...
MISSISSAUGA, Ontario, Feb. 01, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on March 15, 2...
BioSyent press release ( OTCPK:BIOYF ): Q3 GAAP EPS of C$0.12. Revenue of C$6.79M (+1.5% Y/Y). Q3 2022 EBITDA of C$1.95M decreased by 15% versus Q3 2021. For further details see: BioSyent GAAP EPS of C$0.12, revenue of C$6.79M
BioSyent Inc. (BIOYF) Q3 2022 Earnings Conference Call November 16, 2022, 05:00 PM ET Company Participants René Goehrum - President and CEO Conference Call Participants Presentation René Goehrum Hello, and welcome to the Q3 and YTD 2...
The following slide deck was published by BioSyent Inc. in conjunction with their 2022 Q3 earnings call. For further details see: BioSyent Inc. 2022 Q3 - Results - Earnings Call Presentation
BioSyent press release (OTCPK:BIOYF): Q1 GAAP EPS of $0.13. Revenue of $7.04M (-5.1% Y/Y). For further details see: BioSyent GAAP EPS of $0.13, revenue of $7.04M
BioSyent Inc. (BIOYF) Q1 2022 Earnings Conference Call May 18, 2022, 08:00 AM ET Company Participants René Goehrum - President and CEO Conference Call Participants Presentation René Goehrum Hello, and welcome to the BioSyent Inc. Q1 2022 results presentation. My name is René Go...
BioSyent press release (OTCPK:BIOYF): Q4 GAAP EPS of C$0.15. Revenue of C$7.22M (+26.0% Y/Y). For further details see: BioSyent GAAP EPS of C$0.15, revenue of C$7.22M
BioSyent Inc. (BIOYF) Q3 2021 Earnings Conference Call November 18, 2021, 05:00 PM ET Company Participants René Goehrum - President and CEO Conference Call Participants Presentation René Goehrum Hello, and welcome to the BioSyent Inc. Q3 and YTD 2021 results presentation for the nin...
News, Short Squeeze, Breakout and More Instantly...
MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has entered into an agreement with a Euro...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include: Return on Equity for TTM March 31, 2024 was 21% as compared to 15% ...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 20...